AMBITION DX HOLDINGS Co., Ltd. (TYO:3300)

SpringWorks Therapeutics Revenue

AMBITION DX HOLDINGS had revenue of 11.63B JPY in the quarter ending March 31, 2025, with 12.01% growth. This brings the company's revenue in the last twelve months to 49.30B, up 30.20% year-over-year. In the fiscal year ending June 30, 2024, AMBITION DX HOLDINGS had annual revenue of 42.07B with 16.08% growth.

• Revenue (ttm): 49.30B
• Revenue Growth: +30.20%
• P/S Ratio: 0.34
• Revenue / Employee: 139.28M
• Employees: 354
• Market Cap: 16.93B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	42.07B	5.83B	16.08%
Jun 30, 2023	36.24B	4.63B	14.65%
Jun 30, 2022	31.61B	1.08B	3.53%
Jun 30, 2021	30.53B	3.12B	11.36%
Jun 30, 2020	27.41B	-2.22B	-7.50%